''Alli'', First FDA-Approved OTC Weight Loss Product Coming to Local Drugstores Thursday
Posted on: Tuesday, 12 June 2007, 21:00 CDT
Bartell Drugs:
WHAT:
-- Alli is the first FDA-approved, over-the-counter weight loss product. It is now being shipped and will be on local pharmacy shelves beginning Thursday (June 14).
-- Seattle-based Bartell's will be one of the first chains in the market to carry the new product. Anticipating major national coverage for the roll-out of Alli, Bartell's is providing Seattle area media an advance interview/briefing opportunity to educate local consumers about the new product.
-- Though it is a OTC product, Bartell's pharmacists (and other pharmacists) may play a role in providing counsel regarding the use of Alli.
WHEN/WHERE:
-- Noon to 1 p.m., Wednesday June 13; Bartell's location at University Village (across from Eddie Bauer and QFC)
NOTABLE:
-- This is not a "magic bullet" -- rather a product that must be used in conjunction with a low-fat diet and exercise program to work effectively.
-- GlaxoSmithKline has undertaken a major pre-introduction education effort (see www.myalli.com), providing consumers with an array of on-line resources for diet and lifestyle planning to accompany the launch.
-- For additional background, visit the press room link at www.myalli.com/Pressroom/Default.aspx
MEDIA CONTACTS:
Barry Bartlett, The Bartlett Group for Bartell Drugs, cell: 206-335-4694, or barry@bartlettgrouppr.com
Rebecca Siegmund, Bartell Drugs, 206-763-2626
Source: Business Wire
Related Articles
- Indiana Drug Card to Provide Free Drug Cards to Residents
- Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule
- Ramsell Public Health Rx Partners With HealthTrans(R) to Provide Free Drug Discount Program to Public Health Program Participants
- China Halts Production of Novartis Drug
- Walgreen Co. To Acquire Select Assets of Pharmacy and Medical Specialty Product Provider Familymeds Group Inc.
- Nanotechnology-Based Products to Accelerate Drug Discovery Developments
- Pharmaceutical Production in Hungary is Specialised in the Production of Generic Drugs With Nearly 20 Original Molecules Developed During the Last Decade
- Feds Choose 15 Kansas Firms to Provide Medicare Drug Plan
- Telular Products Provide Critical Communications for the Hurricane Katrina Relief Effort
- European Committee for Orphan Medical Products Recommends Orphan Drug Status for AmpliMed's Amplimexon for Pancreatic Cancer
 |
 |
User Comments (0)
RSS Feeds